Skin cancer is the most frequently diagnosed malignancy in the United States. Although invasive melanoma comprises approximately 1% of skin cancers, it is the cause of a vast majority of skin cancer–related deaths. The following provides helpful information related to this malignancy.
Ovarian cancer affects the glands found in women that produce eggs, known as ova, for reproduction. The American Cancer Society estimates that 22,240 women will be diagnosed with new cases of ovarian cancer in 2018, and 14,070 women will die from the disease during the same year.
Patients with indolent subtypes of NHL have a relatively good prognosis with a median survival as long as 20 years, although these subtypes of the disease are typically not curable in advanced stages.
Peripheral neuropathy is the result of damage to the peripheral nervous system, the complex network of nerves that transmits messages between the brain and other parts of the body. Such damage can cause impaired movement, loss of sensation in the arms and legs, numbness, tingling, and pain.
Each year, >200,000 individuals in the United States are diagnosed with a primary or metastatic brain tumor. Primary brain tumors comprise approximately 40,000 of these diagnoses.
Including both children and adults, the American Cancer Society’s estimates for 2016 predict approximately 6590 new cases of ALL (3590 in males and 3000 in females) and approximately 1430 deaths (800 in males and 630 in females) attributable to the disease.
Lymphomas, cancers that begin in lymphatic cells of the immune system, can be divided into 2 main categories: Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL).
With the exception of skin cancer, prostate cancer is the most common cancer affecting men.
In 1962, President John F. Kennedy challenged Americans to go to the moon within a decade. Apollo 11 accomplished that goal 7 years later. In 2012, inspired by that challenge, the University of Texas MD Anderson Cancer Center launched the Moon Shots Program. This ambitious plan aims to convert scientific discoveries into clinical advances quickly to improve survival rates for several of the deadliest cancers including ovarian cancer, which is our focus this month.
National Breast Cancer Awareness Month (NBCAM) originated in October 1985 when the American Cancer Society (ACS) partnered with the pharmaceutical division of Imperial Chemical Industries, now part of AstraZeneca, to sponsor a weeklong event. Today, the ACS is only one of many public and private organizations that help sponsor NBCAM programs in the United States, and Breast Cancer Awareness Month is now observed worldwide.
Page 1 of 2
Results 1 - 10 of 17
Results 1 - 10 of 17